no I expect this is phase 2. They have already established a suitable dose of AMP to take into further trial testing so now it should be case of taking that dose and combining with Folfirinx. We’ll know if/when this study design is communicated and put on clinical trials.gov.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-26
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
